Market Overview:
The global breast cancer treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of breast cancer, technological advancements in the field of breast cancer treatment, and rising awareness about early detection and treatment options for breast cancer. Based on type, the global market for breast cancer treatment is segmented into chemotherapy, radiation therapy, biologic targeted therapy, surgery (breast), and hormone therapy. Of these segments, chemotherapy held the largest share of the global market in 2017.
Product Definition:
A treatment for breast cancer is a medical procedure or regimen that seeks to cure or control the disease. Breast cancer treatments vary, but may include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy and/or stem cell transplantation. The main goal of any breast cancer treatment is to eliminate the tumor while preserving as much healthy tissue as possible.
Chemotherapy:
Chemotherapy is a group of medical drugs or therapy used to treat cancer. Chemotherapy includes drug therapies, biologic response modifiers, and monoclonal antibodies. The most common types of cancers treated with chemotherapy include breast cancer (in women), lung cancer, colorectal cancer, prostate cancer and liver/biliary tract cancers.
Radiation Therapy:
Radiation therapy is a treatment using high energy waves to cure cancer. It's majorly used for the treatment of breast cancer, but it can be used in other types of cancers as well.
Application Insights:
The market is categorized based on the application of the drug and includes hospitals, clinics, ambulatory care units (ACUs), and other facilities. The clinics segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of breast cancer coupled with increasing awareness about early diagnosis. Breast cancer treatment at outpatient departments offers several advantages including convenience for patients as well as healthcare providers. These factors are likely to increase demand over the forecast period.
Oncology drugs are expensive; hence, most patients opt for chemotherapy instead because it costs less and has fewer side effects compared to radiation therapy or hormone therapy.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of technologically advanced treatment methods, and availability of reimbursement coverage. In addition, rising incidence rates and increasing life expectancy are contributing to growth in this region. According to Breastcancer.org statistics published in 2018, 1 out of 3 women will be diagnosed with breast cancer over the course of her lifetime and over 40% percent will die from it within 5 years after diagnosis making it one of the leading causes for mortality among women globally (1).
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving healthcare infrastructure coupled with growing awareness about early diagnosis resulting into higher penetration rates for these therapies especially chemotherapy drugs which are relatively cheaper than radiotherapy or surgery based treatments (2).
Growth Factors:
- Increasing incidence of breast cancer
- Growing awareness about breast cancer and its treatment options
- Rising demand for better and more effective treatments for breast cancer
- Technological advancements in the field of breast cancer treatment
- Availability of government funding and support for research on new treatments for breast cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Breast Cancer Treatment Market Research Report
By Type
Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy
By Application
Hospitals, Clinics, Ambulatory Care Units
By Companies
F. Hoffmann-La Roche, Novartis, Merck, Eli Lilly and Company, Johnson & Johnson, Pfizer, AstraZeneca, GlaxoSmithKline, Sun Pharmaceutical Industries, Bayer, Gilead Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Breast Cancer Treatment Market Report Segments:
The global Breast Cancer Treatment market is segmented on the basis of:
Types
Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Care Units
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F. Hoffmann-La Roche
- Novartis
- Merck
- Eli Lilly and Company
- Johnson & Johnson
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sun Pharmaceutical Industries
- Bayer
- Gilead Sciences
Highlights of The Breast Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Radiation Therapy
- Biologic Targeted Therapy
- Breast Surgery
- Hormone Therapy
- By Application:
- Hospitals
- Clinics
- Ambulatory Care Units
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Breast Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Breast cancer treatment is a combination of surgery, chemotherapy and radiation therapy. Surgery removes the tumor, while chemotherapy and radiation therapy kill any remaining cancer cells.
Some of the key players operating in the breast cancer treatment market are F. Hoffmann-La Roche, Novartis, Merck, Eli Lilly and Company, Johnson & Johnson, Pfizer, AstraZeneca, GlaxoSmithKline, Sun Pharmaceutical Industries, Bayer, Gilead Sciences.
The breast cancer treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Breast Cancer Treatment Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Breast Cancer Treatment Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Breast Cancer Treatment Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Breast Cancer Treatment Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Breast Cancer Treatment Market Size & Forecast, 2018-2028 4.5.1 Breast Cancer Treatment Market Size and Y-o-Y Growth 4.5.2 Breast Cancer Treatment Market Absolute $ Opportunity
Chapter 5 Global Breast Cancer Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Breast Cancer Treatment Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Radiation Therapy
5.2.3 Biologic Targeted Therapy
5.2.4 Breast Surgery
5.2.5 Hormone Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Breast Cancer Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Breast Cancer Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Care Units
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Breast Cancer Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Breast Cancer Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Breast Cancer Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Breast Cancer Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Breast Cancer Treatment Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Radiation Therapy
9.6.3 Biologic Targeted Therapy
9.6.4 Breast Surgery
9.6.5 Hormone Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Breast Cancer Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Care Units
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Breast Cancer Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Breast Cancer Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Breast Cancer Treatment Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Radiation Therapy
10.6.3 Biologic Targeted Therapy
10.6.4 Breast Surgery
10.6.5 Hormone Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Breast Cancer Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Care Units
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Breast Cancer Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Breast Cancer Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Breast Cancer Treatment Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Radiation Therapy
11.6.3 Biologic Targeted Therapy
11.6.4 Breast Surgery
11.6.5 Hormone Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Breast Cancer Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Care Units
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Breast Cancer Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Breast Cancer Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Breast Cancer Treatment Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Radiation Therapy
12.6.3 Biologic Targeted Therapy
12.6.4 Breast Surgery
12.6.5 Hormone Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Breast Cancer Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Care Units
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Breast Cancer Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Breast Cancer Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Breast Cancer Treatment Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Radiation Therapy
13.6.3 Biologic Targeted Therapy
13.6.4 Breast Surgery
13.6.5 Hormone Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Breast Cancer Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Care Units
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Breast Cancer Treatment Market: Competitive Dashboard
14.2 Global Breast Cancer Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F. Hoffmann-La Roche
14.3.2 Novartis
14.3.3 Merck
14.3.4 Eli Lilly and Company
14.3.5 Johnson & Johnson
14.3.6 Pfizer
14.3.7 AstraZeneca
14.3.8 GlaxoSmithKline
14.3.9 Sun Pharmaceutical Industries
14.3.10 Bayer
14.3.11 Gilead Sciences